GMC & Duke Cancer Network In The News
Recent publicity about the new research-based and educational affiliation between Gwinnett Medical Center and Duke Cancer Network is generating lots of buzz on social media. So for our readers who want to know more, here is the full press release we issued regarding this exciting affiliation:
FOR IMMEDIATE RELEASE
For More Information, Contact:
Beth Hardy, APR
Gwinnett Medical Center Offers Proven Knowledge of
Duke Cancer Network to Area
Lawrenceville, Ga. (April 30, 2015) – Recently, Gwinnett Medical Center along with the Duke Cancer Network announced a new research-based and educational affiliation. Gwinnett Medical Center is the only health system in the state to become an affiliate of this network.
“Our affiliation with Duke Cancer Network ensures that our patients have access to an array of clinical trials thus expanding their treatment options to fight cancer,” said Phil Wolfe, Gwinnett Medical Center’s president and CEO. “For some time, GMC has offered robust treatment options through its research capacities; however, this new affiliation takes our program to a new level.”
The affiliation with Duke will provide GMC membership into the National Cancer Institute’s (NCI) Alliance for Clinical Trials. Duke Cancer Institute (DCI) was established and designated by NCI as one of the first comprehensive cancer centers. Through the Network, the DCI offers patients and their providers access to the state-of-the-art research and education programs. These community collaborations also provide patients and their providers with greater access to the most advanced treatments and clinical trials closer to home.
“Gwinnett Medical Center has an existing infrastructure with highly-developed oncology and research capabilities, said Linda Sutton, MD, Medical Director of the Duke Cancer Network. “This partnership builds on GMC’s strengths and provides a host of options for those patients in metro Atlanta.” Dr. Sutton reiterated that one of Duke’s hallmarks is its commitment to excellence through clinical research.
“Through the affiliation, GMC staff and physicians are also afforded a wide range of educational offerings provided by Duke oncology staff and physicians as well as other experts in the field,” said Janet Schwalbe, vice president of physician services at GMC. “Education opportunities will touch on a wide array of topics ranging from the effective use of new cancer therapies to challenges faced by patients following cancer treatments, among others.”
Research is one of many cornerstones of GMC’s breadth of services for cancer patients. GMC patients can also take advantage of patient navigators, financial counselors and free supportive therapies in both the Duluth and Lawrenceville locations. For years, GMC has been committed to providing the community access to these resources; this new affiliation with Duke further complements Gwinnett Medical Center’s Cancer program. Currently, there are only eight organizations in the nation that have this same research affiliation.
About Gwinnett Medical Center
Gwinnett Medical Center is a nationally-recognized, not-for-profit healthcare network with acute-care hospitals in Lawrenceville and Duluth. Offering cardiovascular, orthopedic and neuroscience specialty care as well as a full continuum of wellness services, GMC’s 4,800 associates and 800 affiliated physicians serve more than 400,000 patients annually. To learn more about how GMC is transforming healthcare, visit gwinnettmedicalcenter.org or follow us at facebook.com/gwinnettmedical, twitter.com/gwinnettmedical or youtube.com/gwinnettmedical.
About Duke Cancer Network
The Duke Cancer Network serves to provide an array of oncology related services for diverse affiliates throughout the eastern United States. The DCN links clinicians and patients in the community with the expertise and services of Duke and the Duke Cancer Institute in order to expand options for cancer care. Affiliations with community partners are customized to the clinical, programmatic and research needs of each community. DCN provides mechanisms and infrastructure that support research efforts in the community, allowing many patients to seek clinical trial options close to home.